One important limitation to this study is the difficulty to recruit patients in Brazil for serology studies, thus it remains unknown whether these cytokine changes in serum would also be present in patients with a different TTR mutation and a non-TTR neuropathy (Chronic inflammatory demyelinating polyneuropathy; CIDP). This evidence concerns the gene TTR and chronic inflammatory demyelinating polyradiculoneuropathy.